Personal profile
Headline
PROFESSOR - Neurology PROFESSOR - Otolaryngology PROFESSOR - Neurosurgery
Fingerprint
Dive into the research topics where Joanna Jen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
An optimized variant prioritization process for rare disease diagnostics: recommendations for Exomiser and Genomiser
Undiagnosed Diseases Network, Dec 2025, In: Genome Medicine. 17, 1, 127.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Joint, multifaceted genomic analysis enables diagnosis of diverse, ultra-rare monogenic presentations
Undiagnosed Diseases Network, Dec 2025, In: Nature Communications. 16, 1, 7267.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Rizatriptan vs Placebo for Attacks of Vestibular Migraine A Randomized Clinical Trial
Staab, J. P., Eggers, S. D. Z., Jen, J. C., LeMahieu, A. M., Geske, J. R., Liu, H., Hofschulte, D. R., Gonzalez, G. R., Neff, B. A., Shepard, N. T., McCaslin, D. L. & Baloh, R. W., Jul 2025, In: JAMA Neurology. 82, 7, p. 676-686 11 p.Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations -
The episodic ataxias
Graves, T. D., Snell, H. D., Khodakhah, K., Griggs, R. C. & Jen, J. C., Jan 2024, Handbook of Clinical Neurology. Elsevier B.V., p. 123-133 11 p. (Handbook of Clinical Neurology; vol. 203).Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review
2 Scopus citations -
Correction to: Episodic Ataxia Type 1: Natural History and Effect on Quality of Life (The Cerebellum, (2022), 22, 4, (578-586), 10.1007/s12311-021-01360-6)
the CINCH Investigators, Aug 2023, In: Cerebellum. 22, 4, p. 587 1 p.Research output: Contribution to journal › Comment/debate
Open Access
Press/Media
-
-
Healthy Returns: The launch of breakthrough Alzheimer's drug Leqembi is off to a slow start
20/02/24
6 items of Media coverage
Press/Media
-
-